MedTrace Logo

CardShock Study and Registry

NCT01374867 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2014-01-03

No results posted yet for this study

Summary

The aim of CardShock Study is to recognise significant prognostic factors in order to detect patients with increased mortality risk to which one could possibly direct more intensive treatments.

The study will provide clinical, functional and invasive haemodynamic measures with systematic serial sampling and evaluation. In addition, the knowledge on the pathophysiology of cardiogenic shock is increased.

Conditions

  • Cardiogenic Shock

Sponsors & Collaborators

  • Aarne Koskelo Foundation

    collaborator OTHER

  • Finnish Foundation for Cardiovascular Research

    collaborator OTHER

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Veli-Pekka Harjola, MD, PhD, Associate professor · Helsinki UCH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01374867 on ClinicalTrials.gov